
|Videos|January 13, 2015
How New Agents are Helping Address Clostridium Difficile-Associated Diarrhea Concerns
J. Russell May, PharmD, FASHP, clinical professor at Georgia Regents University College of Pharmacy, discusses how new agents are helping address Clostridium difficile-associated diarrhea concerns.
Advertisement
J. Russell May, PharmD, FASHP, clinical professor at Georgia Regents University College of Pharmacy, discusses how new agents are helping address Clostridium difficile-associated diarrhea concerns.
This interview was recorded at the ASHP 2014 Midyear Clinical Meeting in Anaheim, California.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Semaglutide Shows Direct Organ-Protective Benefits Beyond Weight Loss in HFpEF
2
Immune Synergy May Explain Why Some Patients Achieve Durable Remission With Cilta-Cel
3
Neladalkib Shows Durable Responses in Heavily Pretreated ALK-Positive Lung Cancer
4
November 2025 Pharmacy Policy Updates
5















































































































































































































